v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Cash flows from operating activities:      
Net loss $ (33,685) $ (27,483)  
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation expense 274 291  
Accretion income on marketable securities (292) (501)  
Stock-based compensation expense 3,824 3,514  
Other non-cash items 0 27  
Non-cash lease expense 412 374  
Changes in operating assets and liabilities:      
Prepaid expenses and other assets 1,727 3,003  
Other long-term assets (46) 518  
Accounts payable 1,024 (298)  
Accrued expenses and other liabilities (2,745) (2,475)  
Operating lease liabilities (386) (325)  
Net cash used in operating activities (29,893) (23,355)  
Cash flows from investing activities:      
Purchases of property and equipment (102) (187)  
Maturities of marketable securities 55,000 30,000  
Net cash provided by investing activities 54,898 29,813  
Cash flows from financing activities:      
Proceeds from exercise of stock options 56 0  
Proceeds from exercise of warrants 123 0  
Proceeds from ESPP purchases 121 96  
Net cash provided by financing activities 300 96  
Net increase (decrease) in cash, cash equivalents and restricted cash 25,305 6,554  
Effect of exchange rate changes on cash and cash equivalents (27) (21)  
Cash, cash equivalents and restricted cash at beginning of period 60,283 32,461 $ 32,461
Cash, cash equivalents and restricted cash at end of period 85,561 38,994 $ 60,283
Supplemental disclosure of cash flow information:      
Purchases of property and equipment in accounts payable and accrued expenses and other liabilities $ 20 $ 0